This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19.
New England Journal of Medicine:2022: August 18 Full text
Antibody therapy reverses biological signatures of COVID-19 progression.
Cell Reports Medicine:2022: August 16 Full text
Pathophysiology and Epidemiology
Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study.
BMJ:2022: August 2 Full text
Rash morphology as a predictor of COVID‐19 severity: A systematic review of the cutaneous manifestations of COVID‐19. SVHA
Skin Health and Disease:2022: May 12 Full text
Long COVID symptomatology after 12 months and its impact on quality of life according to initial coronavirus disease 2019 disease severity.
Open Forum Infectious Diseases:2022: August 4 Full text
Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection -a case-control study.
Clinical Infectious Diseases:2022: August 12 Full text
Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Lancet Psychiatry:2022: August 17 Full text
Durability of heterologous and homologous COVID-19 vaccine boosts.
JAMA Network Open:2022: August 10 Full text
COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study.
Lancet Rheumatology:2022: August 16 Full text
Tolerability of COVID-19 infection and messenger RNA vaccination among patients with a history of Kawasaki Disease.
JAMA Network Open:2022: August 12 Full text
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine.
Science Translational Medicine:2022: August 17 Full text
Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study.
Lancet Respiratory Medicine:2022: August 18 Full text
Antibody response in immunocompromised patients with hematologic cancers who received a 3-dose mRNA-1273 vaccination schedule for COVID-19.
JAMA Oncology:2022: August 11 Full text